New member | Satisform
Satisform is a French company based in Le Mans. It designs and produces medical devices used in rehabilitation and preventive... View Article
OSE Immunotherapeutics Receives European Patent Notice of Allowance for First-in-Class CD28-Antagonist Immunotherapy FR104
The patent covers novel dosing regimen of FR104 in Europe through 2036 for therapeutic applications in autoimmune diseases, inflammatory diseases,... View Article
Ceva builds on its preventative health strategy with opening of a new european reference for the manufacture of autogenous vaccines
An innovative project confirms Ceva’s commitment to improving preventative animal health and reducing the use of antibiotics. Beaucouzé, 29 September... View Article
New member | Divoluci
Divoluci is an innovative tool to orientate patients between health professionals in order to ameliorate relationships between local medicine care... View Article
#Coronavirus | Xenothera: phase 2A clinical trial is launched
Since August, the POLYCOR trial has been officially launched in France. It will eventually bring together some thirty hospitals volunteering... View Article
The first in France: the University Hospital of Rennes has deployed the 1st comprehensive digital pathology system, thanks to the NOMINOË fund
The Nominoë Fund, an endowment fund for the University Hospital of Rennes, has enabled the Pathological Anatomy and Cytology Department... View Article
Atlanpole Biotherapies is enjoying sustained dynamic growth and is committed to addressing the challenges of France’s independence in terms of health
The competitiveness cluster is experiencing exponential growth, and currently has 210 members. The 2019 target of increasing the number... View Article
Feedback from the General Assembly on 9th September 2020
Since the beginning of the year, the entire health sector in Western France has been focussing its efforts on the... View Article
New dental health application for Hemarina’s M101 molecule published in Scientific Reports research journal
This demonstration of anti-inflammatory and anti-bacterial properties for treatment of periodontitis validates Hemarina’s technological platform based on the oxygenating molecule... View Article
Valneva Announces Major COVID-19 Vaccine Partnership with the U.K. Government
UK Government has secured supply of 60 million doses at a cost of €470 million with options over another 130 million... View Article